• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症疫苗的功能性树突状细胞生成方法的全面比较研究。

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.

作者信息

Jarnjak-Jankovic Silvija, Hammerstad Hege, Saebøe-Larssen Stein, Kvalheim Gunnar, Gaudernack Gustav

机构信息

Department of Pediatric Research, The National Hospital, Oslo, Norway.

出版信息

BMC Cancer. 2007 Jul 3;7:119. doi: 10.1186/1471-2407-7-119.

DOI:10.1186/1471-2407-7-119
PMID:17608923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1931601/
Abstract

BACKGROUND

Dendritic cells (DCs) are professional antigen-presenting cells with the ability to induce primary T-cell responses and are commonly produced by culturing monocytes in the presence of IL-4 and GM-CSF for 5-7 days (Standard DC). Recently, Dauer and co-workers presented a modified protocol for differentiation of human monocytes into mature DCs within 48 hours (Fast DC). Here we report a functional comparison of the two strategies for generation of DCs from human monocytes with adaptions for large-scale clinical use.

METHODS

The Elutra Cell Selection System was used to isolate monocytes after collection of leukapheresis product. The enriched monocytes were cultured in gas permeable Teflon bags with IL-4 and GM-CSF for 24 hours (Fast DC) or 5 days (Standard DC) to obtain immature DCs. The cells were then transfected with mRNA from the leukemia cell line Jurkat E6 by electroporation and incubated for additional 24 h or 2 days in the presence of pro-inflammatory cytokines (TNFalpha, IL-1beta, IL-6 and PGE2) to obtain mature DCs.

RESULTS

Mature Fast DC and Standard DC displayed comparable levels of many markers expressed on DC, including HLA-DR, CD83, CD86, CD208 and CCR7. However, compared to Standard DC, mature Fast DC was CD14high CD209low. Fast DC and Standard DC transfected with Jurkat E6-cell mRNA were equally able to elicit T cell specifically recognizing transfected DCs in vitro. IFNgamma-secreting T cells were observed in both the CD4+ and CD8+ subsets.

CONCLUSION

Our results indicate that mature Fast DC are functional antigen presenting cells (APCs) capable of inducing primary T-cell responses, and suggest that these cells may be valuable for generation of anti-tumor vaccines.

摘要

背景

树突状细胞(DCs)是专业的抗原呈递细胞,具有诱导初始T细胞反应的能力,通常通过在IL-4和GM-CSF存在的情况下培养单核细胞5至7天来产生(标准DC)。最近,道尔及其同事提出了一种改良方案,可在48小时内将人单核细胞分化为成熟DC(快速DC)。在此,我们报告了两种从人单核细胞生成DC的策略的功能比较,并对其进行了大规模临床应用的适应性调整。

方法

使用Elutra细胞分选系统在采集白细胞分离产品后分离单核细胞。将富集的单核细胞在透气的聚四氟乙烯袋中用IL-4和GM-CSF培养24小时(快速DC)或5天(标准DC)以获得未成熟DC。然后通过电穿孔用白血病细胞系Jurkat E6的mRNA转染细胞,并在促炎细胞因子(TNFα、IL-1β、IL-6和PGE2)存在的情况下再孵育24小时或2天以获得成熟DC。

结果

成熟的快速DC和标准DC在DC上表达的许多标志物水平相当,包括HLA-DR、CD83、CD86、CD208和CCR7。然而,与标准DC相比,成熟的快速DC CD14高CD209低。用Jurkat E6细胞mRNA转染的快速DC和标准DC在体外同样能够引发特异性识别转染DC的T细胞。在CD4+和CD8+亚群中均观察到分泌IFNγ的T细胞。

结论

我们的结果表明,成熟的快速DC是能够诱导初始T细胞反应的功能性抗原呈递细胞(APC),并表明这些细胞可能对生成抗肿瘤疫苗有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/7676e4463a4a/1471-2407-7-119-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/1287c77893a7/1471-2407-7-119-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/74a8d2975d6a/1471-2407-7-119-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/b485138b8462/1471-2407-7-119-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/7676e4463a4a/1471-2407-7-119-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/1287c77893a7/1471-2407-7-119-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/74a8d2975d6a/1471-2407-7-119-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/b485138b8462/1471-2407-7-119-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea6/1931601/7676e4463a4a/1471-2407-7-119-4.jpg

相似文献

1
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.用于癌症疫苗的功能性树突状细胞生成方法的全面比较研究。
BMC Cancer. 2007 Jul 3;7:119. doi: 10.1186/1471-2407-7-119.
2
A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines.一种用于癌症疫苗的临床级mRNA转染单核细胞衍生树突状细胞生成方案。
Scand J Immunol. 2003 Nov;58(5):578-86. doi: 10.1046/j.1365-3083.2003.01333.x.
3
Clinical-scale generation of dendritic cells in a closed system.在封闭系统中进行临床规模的树突状细胞生成。
J Immunother. 2003 Jul-Aug;26(4):374-83. doi: 10.1097/00002371-200307000-00010.
4
Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.生成具有产生生物活性IL-12p70能力的临床级树突状细胞。
J Transl Med. 2007 Apr 12;5:18. doi: 10.1186/1479-5876-5-18.
5
Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.用于癌症免疫治疗的CD14+单核细胞大规模免疫磁选以生成树突状细胞:一项I期研究
J Hematother Stem Cell Res. 2003 Oct;12(5):515-23. doi: 10.1089/152581603322448222.
6
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.第3天在用于癌症免疫治疗试验的CellGro中产生的聚肌苷酸-聚胞苷酸(Poly (I:C))激活的树突状细胞与标准的第5天树突状细胞完全可比。
Immunol Lett. 2014 Jul;160(1):39-49. doi: 10.1016/j.imlet.2014.03.010. Epub 2014 Apr 12.
7
Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.利用源自人单核细胞的功能成熟的2天培养树突状细胞高效诱导针对肿瘤排斥肽的特异性细胞毒性T淋巴细胞。
Int J Oncol. 2006 Nov;29(5):1263-8.
8
Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.使用链球菌制剂OK-432通过一步培养从患者外周血单核细胞生成的成熟树突状细胞具有增强的抗原呈递能力。
Int J Oncol. 2006 Jun;28(6):1481-9.
9
Phenotypic and functional comparison between flask adherent and magnetic activated cell sorted monocytes derived dendritic cells.贴壁培养的单核细胞来源树突状细胞与磁珠分选的单核细胞来源树突状细胞之间的表型和功能比较
Iran J Immunol. 2012 Jun;9(2):98-108.
10
Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells.由CD34+祖细胞或单核细胞产生的树突状细胞在激活抗原特异性CD8+T细胞的能力上存在差异。
J Immunol. 1999 Oct 1;163(7):3597-604.

引用本文的文献

1
Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells.药品生产质量管理规范级树突状细胞生成的最新进展
Transfus Med Hemother. 2020 Dec;47(6):454-463. doi: 10.1159/000512451. Epub 2020 Oct 28.
2
Closing the system: production of viral antigen-presenting dendritic cells eliciting specific CD8 T cell activation in fluorinated ethylene propylene cell culture bags.封闭系统:在氟化乙烯丙烯细胞培养袋中产生引发特异性CD8 T细胞活化的病毒抗原呈递树突状细胞。
J Transl Med. 2020 Oct 9;18(1):383. doi: 10.1186/s12967-020-02543-1.
3
Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment.

本文引用的文献

1
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells.用肿瘤信使核糖核酸转染的树突状细胞接种黑色素瘤患者后的T细胞反应
Cancer Immunol Immunother. 2007 May;56(5):659-75. doi: 10.1007/s00262-006-0222-y. Epub 2006 Sep 1.
2
IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4.干扰素-α促进通过单核细胞与粒细胞-巨噬细胞集落刺激因子和白细胞介素-4短期培养产生的树突状细胞的最终成熟。
J Leukoc Biol. 2006 Aug;80(2):278-86. doi: 10.1189/jlb.1005592. Epub 2006 Jun 12.
3
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.
用于免疫治疗的树突状细胞制造:单核细胞富集。
Mol Ther Methods Clin Dev. 2020 Jan 15;16:155-160. doi: 10.1016/j.omtm.2019.12.017. eCollection 2020 Mar 13.
4
Immunotherapy in Pediatric Solid Tumors-A Systematic Review.儿童实体瘤的免疫治疗——一项系统综述
Cancers (Basel). 2019 Dec 14;11(12):2022. doi: 10.3390/cancers11122022.
5
IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation.IL-15 在树突状细胞分化过程中产生同时表达淋巴-髓系标记的 IFN-γ 产生细胞。
Int J Biol Sci. 2019 Jan 1;15(2):464-480. doi: 10.7150/ijbs.25743. eCollection 2019.
6
Use of antigen-primed dendritic cells for inducing antitumor immune responses in patients with non-small cell lung cancer.使用抗原致敏树突状细胞诱导非小细胞肺癌患者的抗肿瘤免疫反应。
Oncol Lett. 2018 Jan;15(1):1297-1306. doi: 10.3892/ol.2017.7403. Epub 2017 Nov 14.
7
Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.使用转染了编码HER2/neu肿瘤抗原表位的DNA构建体的树突状细胞生成抗原特异性细胞毒性T细胞群体。
BMC Immunol. 2017 Jun 20;18(1):31. doi: 10.1186/s12865-017-0219-7.
8
Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects.肝硬化患者单核细胞来源的树突状细胞与健康受试者的细胞在成熟/激活及抗原呈递方面具有相似的能力。
Cell Immunol. 2015 May;295(1):36-45. doi: 10.1016/j.cellimm.2015.02.008. Epub 2015 Feb 25.
9
Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.通过与第3天树突状细胞进行电融合制备三阴性乳腺癌疫苗。
PLoS One. 2014 Jul 18;9(7):e102197. doi: 10.1371/journal.pone.0102197. eCollection 2014.
10
Dendritic cells derived from pluripotent stem cells: Potential of large scale production.源自多能干细胞的树突状细胞:大规模生产的潜力。
World J Stem Cells. 2014 Jan 26;6(1):1-10. doi: 10.4252/wjsc.v6.i1.1.
用自体肿瘤信使核糖核酸转染的树突状细胞进行黑色素瘤治疗的I/II期试验
Cancer Gene Ther. 2006 Oct;13(10):905-18. doi: 10.1038/sj.cgt.7700961. Epub 2006 May 5.
4
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells.用肿瘤信使核糖核酸转染的树突状细胞进行癌症的免疫基因治疗。
Cancer Immunol Immunother. 2006 Nov;55(11):1432-42. doi: 10.1007/s00262-006-0161-7. Epub 2006 Apr 13.
5
Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.树突状细胞特异性细胞间黏附分子3结合非整合素/CD209在正常人淋巴结的巨噬细胞上大量存在,并且在混合淋巴细胞反应中树突状细胞刺激过程中并非必需。
J Immunol. 2005 Oct 1;175(7):4265-73. doi: 10.4049/jimmunol.175.7.4265.
6
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients.雄激素抵抗性前列腺癌患者中使用同种肿瘤mRNA转染树突状细胞的免疫疗法。
Br J Cancer. 2005 Oct 3;93(7):749-56. doi: 10.1038/sj.bjc.6602761.
7
Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma.用mRNA转染或负载凋亡细胞的自体树突状细胞用于高危神经母细胞瘤免疫治疗的临床前评估。
Cancer Gene Ther. 2005 Aug;12(8):699-707. doi: 10.1038/sj.cgt.7700820.
8
Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination.用于黑色素瘤疫苗接种的自体肿瘤信使核糖核酸转染树突状细胞的临床前全面评估。
Cancer Gene Ther. 2005 Jun;12(6):579-91. doi: 10.1038/sj.cgt.7700837.
9
Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells.从纯化的冷冻 CD34(+) 血液祖细胞生成 mRNA 转染树突状细胞的临床级程序的开发。
Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):255-63. doi: 10.1177/039463200401700305.
10
Dendritic cell differentiation.树突状细胞分化
J Immunol. 2004 Jan 1;172(1):3; author reply 3-4. doi: 10.4049/jimmunol.172.1.3.